DYRK1A and Alzheimer disease: Even if DS patients with AD have a distinct neuroinflammatory phenotype compared to sporadic AD [33], we could hypothesize that the decrease of full-length form of DYRK1A associated with the increase of truncated form could be due to an increase of calpain 1 activity in symptomatic DS groups.